210 related articles for article (PubMed ID: 8239592)
1. Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
Paulfeuerborn W; Müller HJ; Borner K; Koeppe P; Lode H
Antimicrob Agents Chemother; 1993 Sep; 37(9):1835-41. PubMed ID: 8239592
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Paradis D; Vallée F; Allard S; Bisson C; Daviau N; Drapeau C; Auger F; LeBel M
Antimicrob Agents Chemother; 1992 Oct; 36(10):2085-92. PubMed ID: 1444289
[TBL] [Abstract][Full Text] [Related]
3. Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem-cilastatin.
Dreetz M; Hamacher J; Eller J; Borner K; Koeppe P; Schaberg T; Lode H
Antimicrob Agents Chemother; 1996 Jan; 40(1):105-9. PubMed ID: 8787889
[TBL] [Abstract][Full Text] [Related]
4. Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections.
Nicolau DP; Nightingale CH; Banevicius MA; Fu Q; Quintiliani R
Antimicrob Agents Chemother; 1996 Jan; 40(1):61-4. PubMed ID: 8787880
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections.
Benko AS; Cappelletty DM; Kruse JA; Rybak MJ
Antimicrob Agents Chemother; 1996 Mar; 40(3):691-5. PubMed ID: 8851594
[TBL] [Abstract][Full Text] [Related]
6. Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.
Kemmerich B; Warns H; Lode H; Borner K; Koeppe P; Knothe H
Antimicrob Agents Chemother; 1983 Sep; 24(3):333-8. PubMed ID: 6357074
[TBL] [Abstract][Full Text] [Related]
7. Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Wagenlehner FM; Wydra S; Onda H; Kinzig-Schippers M; Sörgel F; Naber KG
Antimicrob Agents Chemother; 2003 Dec; 47(12):3789-94. PubMed ID: 14638484
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid.
Kalman D; Barriere SL; Johnson BL
Antimicrob Agents Chemother; 1992 Feb; 36(2):453-7. PubMed ID: 1605609
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1995 Nov; 39(11):2503-10. PubMed ID: 8585734
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers.
Drusano GL; Standiford HC; Fitzpatrick B; Leslie J; Tangtatsawasdi P; Ryan P; Tatem B; Moody MR; Schimpff SC
Antimicrob Agents Chemother; 1984 Sep; 26(3):388-93. PubMed ID: 6391372
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.
Mouton JW; Horrevorts AM; Mulder PG; Prens EP; Michel MF
Antimicrob Agents Chemother; 1990 Dec; 34(12):2307-11. PubMed ID: 2088186
[TBL] [Abstract][Full Text] [Related]
12. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
13. Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method.
Manduru M; Mihm LB; White RL; Friedrich LV; Flume PA; Bosso JA
Antimicrob Agents Chemother; 1997 Nov; 41(11):2527-32. PubMed ID: 9371361
[TBL] [Abstract][Full Text] [Related]
14. Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.
Deeter RG; Weinstein MP; Swanson KA; Gross JS; Bailey LC
Antimicrob Agents Chemother; 1990 Jun; 34(6):1007-13. PubMed ID: 2393258
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of ceftazidime with an elastomeric infusion device.
Couldry R; Sanborn M; Klutman NE; Strayer AH
Am J Health Syst Pharm; 1998 Jan; 55(2):145-9. PubMed ID: 9465978
[TBL] [Abstract][Full Text] [Related]
16. Serum bactericidal activity of ceftazidime increased by netilmicin.
LeBel M; Pellerin M; Bergeron MG
Drug Intell Clin Pharm; 1985 Dec; 19(12):932-6. PubMed ID: 3910388
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.
Nau R; Prange HW; Kinzig M; Frank A; Dressel A; Scholz P; Kolenda H; Sörgel F
Antimicrob Agents Chemother; 1996 Mar; 40(3):763-6. PubMed ID: 8851607
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetic comparison and pharmacodynamic breakpoints of ceftazidime in cystic fibrosis patients and healthy volunteers.
Bulitta JB; Landersdorfer CB; Hüttner SJ; Drusano GL; Kinzig M; Holzgrabe U; Stephan U; Sörgel F
Antimicrob Agents Chemother; 2010 Mar; 54(3):1275-82. PubMed ID: 20065059
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ex-vivo serum bactericidal activity of cefepime, ceftazidime and cloxacillin against Staphylococcus aureus.
Dan M; Asherov J; Poch F
Diagn Microbiol Infect Dis; 1999 Jan; 33(1):39-42. PubMed ID: 9990474
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of ceftazidime against Pseudomonas aeruginosa under conditions simulating serum pharmacokinetic.
Shah PM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():135-40. PubMed ID: 19802977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
